
|Articles|August 18, 2021
Pharmacy Clinical Pearl of the Day: Non-alcoholic Steatohepatitis
Author(s)Saro Arakelians, PharmD
Non-alcoholic steatohepatitis is the most severe form of non-alcoholic fatty liver disease.
Advertisement
Clinical Pearl of the Day: Non-alcoholic steatohepatitis (NASH)
NASH is defined as the liver manifestation of a metabolic disorder and is the most severe form of non-alcoholic fatty liver disease (NAFLD).
Explanation:
- NAFLD is a condition in which fat builds up in the liver.
- Nonalcoholic fatty liver (NAFL) and NASH are types of NAFLD.
- Patients with NASH, develop inflammation and liver damage, along with fat in the liver.
- Physicians use patients’ medical history, a physical exam, and tests to diagnose NAFLD.
- They can also use blood tests, imaging tests, and liver biopsy to diagnose NAFLD and tell the difference between NAFL or NASH.
Reference
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events
3
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
4
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
5


























